CEO Interview
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Developing and commercializing active ingredients from natural sources for healthcare and personal care industries.
Learn More about our ProductsPGX technology is a novel spray drying technique for processing water-soluble biopolymers which utilizes the unique and tunable properties of Pressurized Gas eXpanded liquids.
Learn More About PGXTSX Venture
CZO
Change
Volume
Day Range
52 Week Range
OTCQX Markets
CRPOF
Change
Volume
Day Range
52 Week Range
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.
View our latest corporate presentation to learn more about Ceapro, our products and our proprietary manufacturing technology.
View PresentationCeapro isolates ingredients from oat products, such as Avenanthramides and Beta Glucan, and botanical products to naturally enhance popular cosmetic and personal care products.
View Our Products
Ceapro Announces Results of 2022 Shareholders’ Meeting
Jun 7, 2022 | Read More
Ceapro Inc. to Present at the H.C. Wainwright Global Investment Conference
May 23, 2022 | Read More
Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update
May 18, 2022 | Read More
Ceapro Inc. to Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids
May 13, 2022 | Read More